BioPortfolio - Cypress Bioscience
Cypress Bioscience - Entry on Bioportfolio's Biocorporate Database. ... where CNS mechanisms have a strong influence on somatic or bodily symptoms, ...
http://www.bioportfolio.com/biocorporate/3162-Cypress_Biosci...
|
BioPortfolio - BioScience Laboratories - Profile
BioNews Results for BioScience Laboratories. • Buy Cypress Bioscience ... Forest /Cypress present more strong Phase III milnacipran data ...
http://www.bioportfolio.com/biocorporate/19772-BioScience%25...
|
BioPortfolio - BioScience Laboratories - Profile
Buy Cypress Bioscience. TradingMarkets: Dec 20 2008 12:34PM Matching: bioscience ... Forest/Cypress present more strong Phase III milnacipran data ...
http://www.bioportfolio.com/biocorporate/19772-BioScience%25...
|
BioPortfolio - MitoScan Product CenterHarvard Bioscience, Inc ...
strong positions in niche markets within life science research: ... Buy Cypress Bioscience. TradingMarkets: Dec 20 2008 12:34PM Matching: product bioscience ...
http://www.bioportfolio.com/biocorporate/26630-MitoScan+Prod...
|
BioPortfolio - BioScience Laboratories - Profile
Forest/Cypress present more strong Phase III milnacipran data. Pharma Times: Dec 9 2008 7:56PM Matching: bioscience laboratories ...
http://www.bioportfolio.com/biocorporate/19772-BioScience%2B...
|
BioPortfolio - MitoScan Product CenterHarvard Bioscience, Inc.
Zacks Analyst Blog Highlights: Qualcomm, Inc., Nokia, Johnson & Johnson, Cypress Bioscience, Inc. and Forest L, DiGiTAL50: Dec 23 2008 7:49PM Matching: ...
http://www.bioportfolio.com/biocorporate/26630-MitoScan_Prod...
|
BioPortfolio - HISTO-LINE Laboratories - Profile
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase ... Forest/Cypress present more strong Phase III milnacipran data ...
http://www.bioportfolio.com/biocorporate/4993-HISTO-LINE+Lab...
|
BioPortfolio - Abitibi-Consolidated Inc. - Profile
Tongli Pharmaceuticals Announces Strong Revenue and Net Income Growth in Second Quarter of ... Cypress Bioscience, Inc. Announces Third Quarter 2008 Results ...
http://www.bioportfolio.com/biocorporate/17691-Abitibi-Conso...
|
BioPortfolio - Pierre Fabre - Profile
Forest/Cypress present more strong Phase III milnacipran data. Pharma Times: Dec 9 2008 7:56PM Matching: pierre fabre. • Cypress Bioscience, Inc. Announces ...
http://www.bioportfolio.com/biocorporate/8367-Pierre+Fabre.p...
|
Biotechnology and Pharmaceutical Industry Search Find Companies ...
Shengtai Pharmaceutical Strong Speculative Buy Rating in Update Coverage by Dutton ... Zacks Bull and Bear of the Day Highlights: Cypress Biosciences, ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|